Laboratory experiments have reported that IL-6 induces skeletal muscle atrophy [26], and the inhibition of IL-6 can attenuate skeletal muscle atrophy caused by denervation [27], cancer cachexia [28], and disuse [29]. The gene discussed is IL6; the disease is cancer.